Moreover, SCN5A mutation carriers tend to exhibit “cardiac sodium channelopathy overlap syndrome,” with overlapping clinical manifestations of the distinct SCN5A-related syndromes such as long QT syndrome type 3 or Brugada syndrome, and an altered cardiac conduction in many cases [44]. This evidence concerns the gene SCN5A and long QT syndrome 3.